Bedrijfstakpensioenfonds Voor De Media Pno Biogen Inc. Transaction History

Bedrijfstakpensioenfonds Voor De Media Pno

$773 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 14, 2020	SELL	$264.77 - $305.71 $10.9 Million - $12.5 Million	-41,000 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $1.29 Million - $1.71 Million	-5,000 Reduced 10.87%	41,000 $9.77 Million
Q3 2019 Dec 03, 2019	SELL	$217.44 - $243.88 $3.26 Million - $3.66 Million	-15,000 Reduced 24.59%	46,000 $10.7 Million
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $4.55 Million - $7.12 Million	21,000 Added 52.5%	61,000 $14.4 Million
Q2 2018 Jul 18, 2018	BUY	$257.52 - $306.91 $2.06 Million - $2.46 Million	8,000 Added 25.0%	40,000 $11.6 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $9 Million - $10.6 Million	32,000	32,000 $10 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedrijfstakpensioenfonds Voor De Media Pno, based on Form 13F filings with the SEC.

News

Stay updated on Bedrijfstakpensioenfonds Voor De Media Pno with notifications on news.

Account